Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xenetic Biosciences Inc (XBIO)

Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Xenetic Biosciences, Inc. Announces Executive Leadership Transition

Company's Board of Directors Appoint James F. Parslow to Interim Chief Executive Officer

XBIO : 3.74 (-8.69%)
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

FRAMINGHAM, MA / ACCESSWIRE / May 10, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...

XBIO : 3.74 (-8.69%)
Xenetic Biosciences: Q1 Earnings Snapshot

Xenetic Biosciences: Q1 Earnings Snapshot

XBIO : 3.74 (-8.69%)
Xenetic Dips on Full-Year Results

Xenetic Biosciences, Inc. (NASDAQ:XBIO) shares began Friday negative, as the company, based out of Framingham, ...

XBIO : 3.74 (-8.69%)
Xenetic Biosciences: Q3 Earnings Snapshot

Xenetic Biosciences: Q3 Earnings Snapshot

XBIO : 3.74 (-8.69%)
Xenetic Biosciences, Inc. Reports Third Quarter 2023 Financial Results

FRAMINGHAM, MA / ACCESSWIRE / November 10, 2023 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies...

XBIO : 3.74 (-8.69%)
JTC Team Announces Presenting Company Line Up for the Virtual Investor “Ask the CEO” Conference Being Held October 24-25, 2023

- Live video webcast interactive Q&A with participating companies -

EVFM : 0.0096 (+1.05%)
GRI : 1.6000 (-2.44%)
MBRX : 3.63 (+1.68%)
XBIO : 3.74 (-8.69%)
AREC : 0.6551 (-8.12%)
CNSP : 1.4600 (+15.87%)
NVNO : 5.05 (-0.39%)
PALI : 4.35 (-4.19%)
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference

Live moderated webcast with Jeffrey Eisenberg, Chief Executive Officer of Xenetic Biosciences on Tuesday, October 24th at 1:00 PM ET

XBIO : 3.74 (-8.69%)
Xenetic Biosciences: Q2 Earnings Snapshot

Xenetic Biosciences: Q2 Earnings Snapshot

XBIO : 3.74 (-8.69%)
Xenetic Biosciences: Q1 Earnings Snapshot

Xenetic Biosciences: Q1 Earnings Snapshot

XBIO : 3.74 (-8.69%)

Barchart Exclusives

2 High-Yield Stocks With New 'Buy' Ratings from Goldman
Goldman Sachs initiated AT&T and Verizon with bullish coverage, citing a favorable telecom industry backdrop and attractive dividend yields, as the sector undergoes major transformation with significant investments in 5G and network infrastructure. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar